BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30701736)

  • 1. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
    Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
    Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
    Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
    Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention.
    Shehata M
    J Interv Cardiol; 2014 Oct; 27(5):472-81. PubMed ID: 25174952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
    Pang Z; Zhao W; Yao Z
    Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).
    Kawakita N; Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Nakamura K; Ito H;
    PLoS One; 2018; 13(4):e0194623. PubMed ID: 29659585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
    Pelliccia F; Pasceri V; Marazzi G; Rosano G; Greco C; Gaudio C
    Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen phosphorylase isoenzyme BB, creatine kinase isoenzyme MB and troponin I for monitoring patients with percutaneous coronary intervention - a pilot study.
    Skitek M; Kranjec I; Jerin A
    Med Glas (Zenica); 2014 Feb; 11(1):13-8. PubMed ID: 24496335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions - Subanalysis of a Randomized Controlled Trial.
    Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Nakamura K; Ito H;
    Circ J; 2018 Jun; 82(7):1788-1796. PubMed ID: 29669963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
    Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
    Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
    Zhao XT; Zhang CF; Liu QJ
    BMC Cardiovasc Disord; 2019 Jun; 19(1):144. PubMed ID: 31200660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Aslanabadi N; Shirzadi HR; Asghari-Soufi H; Dousti S; Ghaffari S; Sohrabi B; Mashayekhi SO; Hamishehkar H; Entezari-Maleki T
    Eur J Clin Pharmacol; 2015 Feb; 71(2):143-9. PubMed ID: 25475357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial.
    Aslanabadi N; Jafaripor I; Sadeghi S; Hamishehkar H; Ghaffari S; Toluey M; Azizi H; Entezari-Maleki T
    J Clin Pharmacol; 2018 Feb; 58(2):144-151. PubMed ID: 28841229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of remote ischemic preconditioning on myocardial injury and endothelial function and prognosis after percutaneous coronary intervention in patients with acute coronary syndrome.
    Zhou FZ; Song W; Yin LH; Song ZF; Yang S; Yang FB; Liu JF; Song YG; Zhang HY; Zhang ZM
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4642-4648. PubMed ID: 29131250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention.
    Aslanabadi N; Safaie N; Asgharzadeh Y; Houshmand F; Ghaffari S; Garjani A; Dousti S; Hamishehkar H; Entezari-Maleki T
    Cardiovasc Ther; 2016 Aug; 34(4):254-60. PubMed ID: 27214383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Bressi E; Mangiacapra F; Ricottini E; Cavallari I; Colaiori I; Di Gioia G; Creta A; Di Sciascio G
    Am J Cardiol; 2016 Oct; 118(7):980-4. PubMed ID: 27515894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicorandil suppressed myocardial injury after percutaneous coronary intervention.
    Isono T; Kamihata H; Sutani Y; Motohiro M; Yamamoto S; Kyoui S; Iharada Y; Kurimoto K; Hara K; Takahashi H; Iwasaka T
    Int J Cardiol; 2008 Jan; 123(2):123-8. PubMed ID: 17346816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Sun F; Yin Z; Shi Q; Zhao B; Wang S
    Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation.
    Luo SJ; Zhou YJ; Shi DM; Ge HL; Wang JL; Liu RF
    Can J Cardiol; 2013 Sep; 29(9):1084-9. PubMed ID: 23414904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.